These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22533828)

  • 21. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
    Karabsheh S; Verma DR; Jain M; Stoddard G; Brunisholz K; Stehlik J; Kfoury A; Gilbert E; Bader F
    Am J Cardiol; 2011 Dec; 108(12):1836-9. PubMed ID: 22133132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
    Lattanzio MR; Weir MR
    Curr Hypertens Rep; 2010 Oct; 12(5):369-77. PubMed ID: 20703958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).
    Ritter JM
    Br J Clin Pharmacol; 2011 Mar; 71(3):313-5. PubMed ID: 21284691
    [No Abstract]   [Full Text] [Related]  

  • 24. The evolution of angiotensin blockade in the management of cardiovascular disease.
    Nantel P; René de Cotret P
    Can J Cardiol; 2010 Dec; 26 Suppl E():7E-13E. PubMed ID: 21620285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is dual renin-angiotensin-system blockade associated with increased risk of stroke?
    Makani H; Bangalore S; Sever P; Messerli FH
    JACC Heart Fail; 2013 Oct; 1(5):454-7. PubMed ID: 24621979
    [No Abstract]   [Full Text] [Related]  

  • 27. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
    Goel SS; Aksoy O; Gupta S; Houghtaling PL; Tuzcu EM; Marwick T; Mihaljevic T; Svensson L; Blackstone EH; Griffin BP; Stewart WJ; Barzilai B; Menon V; Kapadia SR
    Ann Intern Med; 2014 Nov; 161(10):699-710. PubMed ID: 25402513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor.
    Zhou A; Yu L; Li J; Zhang J; Wang H
    Hypertens Res; 2000 Jul; 23(4):391-7. PubMed ID: 10912779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this.
    Pende A; Montecucco F
    Curr Pharm Des; 2012; 18(7):950-1. PubMed ID: 22283769
    [No Abstract]   [Full Text] [Related]  

  • 30. Should ACE inhibitors and ARBs be used in combination in children?
    Stotter BR; Ferguson MA
    Pediatr Nephrol; 2019 Sep; 34(9):1521-1532. PubMed ID: 30112656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
    Mercier K; Smith H; Biederman J
    Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present and future in the treatment of diabetic kidney disease.
    Quiroga B; Arroyo D; de Arriba G
    J Diabetes Res; 2015; 2015():801348. PubMed ID: 25945357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Marathias KP; Agroyannis B; Mavromoustakos T; Matsoukas J; Vlahakos DV
    Curr Top Med Chem; 2004; 4(4):483-6. PubMed ID: 14965314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D
    Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapy.
    Morishita Y; Kusano E
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):241-6. PubMed ID: 22023537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
    Iijima K; Hamahira K; Kobayashi A; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 2000 Dec; 11(12):2265-2271. PubMed ID: 11095649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
    Epstein BJ; Leonard PT; Shah NK
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):713-25. PubMed ID: 22894628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined blockade of renin-angiotensin-aldosterone system reduced all-cause but not cardiovascular mortality in dialysis patients: A mediation analysis and systematic review.
    Li SM; He WB; Chen J; Cai QQ; Huang FF; Zhang K; Wang JF; Liu X; Huang H
    Atherosclerosis; 2018 Feb; 269():35-41. PubMed ID: 29258005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
    Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.